AI visionary to speak at DDW Concept to Cure track at SLAS2025
Dr Raminderpal Singh, Global Head of AI & GenAI Practice, 20/15 Visioneers, will be speaking at DDW‘s track – Concept to Cure: Curiosity and Lab Automation in Drug Discovery – at SLAS2025 (25-29 January 2025, San Diego, USA).
This free programme will present examples of research and drug development from industry experts using lab automation and technology in the Ignite Theater on 27, 28 and 29 January.
Singh’s talk is entitled Taking the plunge: Getting large language models to reliably and cost-efficiently work for you.
Singh is a recognised visionary in the implementation of AI & GenAI across technology and science-focused industries. He has over 30 years of global experience leading and advising teams, helping early to mid-stage companies achieve breakthroughs through the effective use of computational modelling – including taking Watson Genomics to market for IBM Research.
Speaker line-up:
- Dr Raminderpal Singh, 20/15 Visioneers
- Nicola Richmond, Expert in AI and lab technologies in drug discovery
- Graham T Dempsey, Quiver Biosciences
- Fatah Kashanchi, George Mason University and Heather Branscome, ATCC
- Alexander G Godfrey, National Center for Advancing Translational Sciences (NCATS)
- Carleen Klumpp-Thomas, National Center for Advancing Translational Sciences (NCATS)
The track is sponsored by ATCC, Integra Biosciences, Collaborative Drug Discovery (CDD) and Tecan.
